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Abstract 
In the modern world, a lack of magnesium in the body is one of the most common deficient conditions in 
humans. Low levels of magnesium have been associated with a number of chronic diseases. This work is 
devoted to the study of the effect of the use of the balneological means "Magnesium oil" for the correction 
of the manifestations of experimentally induced magnesium deficiency. The experiment was conducted on 
50 white female rats of the Wistar auto-breeding line which were divided into 3 equal groups: (1) control, 
(2) model of magnesium deficiency, (3) received "Magnesium oil". As a result of modeling the state of 
magnesium deficiency, significant changes are observed in the central nervous system, vegetative nervous 
system, and kidneys of animals. The use of balneological means "Magnesium oil" can significantly reduce 
the negative manifestations of magnesium deficiency. 
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Introduction 
Magnesium is one of the most important nutrients. It 
is the fourth most common mineral in the human 
body after calcium, sodium, and potassium and is 
the second most common intracellular cation after 
potassium. Magnesium has several functions in the 
human body. It acts as a cofactor for more than 300 
enzymes, regulating a number of fundamental 
functions such as muscle contraction, neuromuscular 
conduction, glycemic control, myocardial 
contraction, and blood pressure (1, 2). Moreover, 
magnesium also plays a vital role in energy 
production, active transmembrane transport for other 
ions, synthesis of nuclear materials, and bone 
development (3, 4). Because of magnesium’s many 
functions within the body, it plays a major role in 
disease prevention and overall health. Low levels of 
magnesium have been associated with a number of 
chronic diseases including migraine headaches, 
Alzheimer’s disease, cerebrovascular accident 
(stroke), hypertension, cardiovascular disease, and 
type 2 diabetes mellitus (5, 6, 7, 8)   
Magnesium must be continuously replenished 
through foods and water intake because it is not 
synthesizable. Chronic inadequate intake of 
magnesium over long period of time can manifest as 
latent magnesium deficiency with symptoms such as 
muscle weakness, cramps, fatigue, neurological and 
cardiovascular dysfunctions, reduced bone 
mineralization and strength. Reports published by 
WHO have estimated that ~two thirds of Americans 
and French have magnesium intake below the 
recommended amounts but only a small numbers are 
overtly depleted (9).    
In the modern world, a lack of magnesium in the 
body is one of the most common deficient 
conditions in humans. The concentration of 
magnesium in the body decreases under the 
influence of various factors: living conditions and 
nutrition, age, physical activity, physiological 
(pregnancy, lactation) and pathological conditions 
(disease of the cardiovascular, urinary systems, 
digestive organs, endocrine glands). Today, two 
definitions are used to indicate magnesium 
metabolism disorders: “magnesium deficiency” - a 
decrease in the total magnesium content in the body 
and “hypomagnesemia” - a decrease in the 
concentration of magnesium in the blood serum of 
less than 0.75-1.2 mmol/l (10, 11). 
A moderate deficiency of magnesium in the body is 
evidenced by its levels in the blood serum of 0.5-0.7 
mmol/L, expressed (life-threatening) - below 0.5 
mmol/L (12). 
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Currently, a whole pharmaceutical industry is 
working to fill the magnesium deficiency. However, 
the use of drugs is not always effective, may be 
accompanied by side effects, which makes it 
relevant to a search for new non-drug treatment 
strategies. In this context, it seems reasonable to use 
mineral water (MW) in complex treatment, because, 
in its therapeutic effects, MW often exceeds many 
medicines. However, they do not have side effects 
and allergic reactions, overloading the patient's body 
with chemicals (13, 14, 15, 16). 
This work is devoted to the study of the effect of the 
use of the balneological means "Magnesium oil" for 
the correction of the manifestations of 
experimentally induced magnesium deficiency. The 
"Magnesium oil" is a natural balneological product 
containing 95% magnesium chloride. The main 
attention was directed to studying the dynamics of 
the state of the nervous system and kidney function, 
since, according to published data, they mainly 
suffer the most with deficiency of magnesium in the 
body (17-26). 
Materials and methods.  
The experiment was conducted on 50 white female 
rats of the Wistar auto-breeding line with a 
bodyweight of 180 - 210 g. The studies were 
conducted in accordance with the rules established 
by the Directive of the European Parliament and the 
Council (2010/63 / EU) and the order of the 
Ministry of Education and Science, Youth and 
Sports of Ukraine dated 24.03.2012 No. 249 "On 
approval of the Procedure for conducting scientific 
experiments, experiments on animals" (27, 28). 
Reproduction of a model of magnesium deficiency 
(MMD) in the body of experimental animals was 
carried out with the involvement of a special diet. 
White rats were kept on a magnesium-depleted diet 
containing 30% casein, 45% potato starch, 10% corn 
oil, 20% white breadcrumbs. The diet was prepared 
in distilled water, the same water was used as 
drinking water. This diet was obtained from the 
background of the development of chronic psycho-
emotional immobilization stress (distress), 
exacerbated by situational components, for which 
the animals were periodically immobilized for 3 
hours each day by placing rats in a special device 
consisting of individual cells restricting the 
movement of animals. The emotional component of 
distress was reproduced by adding to the above 
methodology situational components, namely, by 
changing the mode of feeding, lengthening the 
daylight, overpopulation. The experimental 
pathology was reproduced for 70 days. 
Before the start of the study, rats were divided into 3 
equal groups: 
Group 1 (20 pcs.) Is an intact animal that serves as a 
control group; 
Group 2 (10 pcs.) - in which the state of magnesium 
deficiency is reproduced 
Group 3 (10 pcs.) - animals that received a solution 
of the balneological product "Magnesium oil" with a 
concentration of magnesium 0.5g/l from the 70th 
day, in the mode of internal use, against the 
background of the MMD development. The solution 
was introduced into the esophagus by animals with a 
soft probe with olive once a day (in the afternoon) at 
a dose of 1% of body weight at a rate of 7 days in a 
row. 
The evaluation of the development of the 
pathological model and the study of the effect of 
balneological agent "Magnesium oil" on the body of 
experimental animals were performed by the 
following tests. 
Effects on the nervous system of rats were 
investigated using the "open field" method, which is 
a prognostic criterion of the central nervous system 
(CNS) condition, which is characterized by the 
ratios of orientational-research behavior, displaced 
and motor activity. The condition of the vegetative 
nervous system (VNS) was assessed by changes in 
emotional activity. 
When studying the behavior of animals in the 
device, the number of exits to the center, intersecting 
squares, racks, peeps into minks, clearings 
(grooming), movements and seats in place (boluses 
and urinations) were recorded. When processing the 
results, the following totals dates were calculated: 
–– Motor activity (MA) - the sum of the number of 
exits to the center and the number and duration of 
animal stops; 
–– Orienteering Research Behavior (ORB) - the sum 
of the number of squares crossed, uprights, mink 
views; 
–– Emotional activity (EA) is the sum of the number 
and duration of grooming (cleansing) sum of 
urinations, bowel movements (boluses); 
- The functional state of the kidneys was evaluated 
by the influence on the urinary function (glomerular 
filtration rate, tubular reabsorption, diuresis), on the 
excretory function (on the excretion of creatinine 
 307 
 
and urea) and ion-regulating function (on the 
concentration and daily excretion of ions. 
Determined the acid-alkaline reaction of daily urine 
in terms of the concentration of hydrogen ions; 
 - The concentration of sodium, potassium, calcium 
and chloride ions in whole blood and urine was 
determined on an instrument for the determination 
of electrolytes in biological fluids of AEK-01 
"Kwer". 
The statistical processing of the obtained data was 
carried out by the method of indirect differences, 
while the significant shifts were those that were 
within the probability of the Student's criterion P 
<0.05. 
Results and discussion 
Table 1 shows the data that determine the functional 
state of the CNS and the emotional activity of rats 
with the MMD model when conducting experiments 
in the device "open field". 
 
Table 1. Functional state of the CNS and emotional activity of 
rats, (M ± m) 
                
Indicators 
Group 1 Group 2 Group 3 
(М1 ± m1) (M2 ± m2) (M3 ± m3) 
Number of exits 
to the center, n 
1.85 ± 0.25 
 
0.70 ± 0.02  
P1 < 0.001 
1.79 ± 0.27 
 
Stops, n 2.04 ± 0.14  
3.03 ± 0.01 
P1 < 0.01 
2.07± 0.03 
P2 > 0.5 
Stops, s 66.78 ± 7.55  
146.50±0.54 
P1 < 0.01 
257.83± 2.83 
P2 < 0.01 
Number of 
squares crossed, n 
69.82 ± 2.39 
 
31.47±0.12 
P1 < 0.01 
10.49 ± 0.42 
P2< 0.01 
Number of 
uprights, n 14.37 ± 1.07 
6.59±0.03 
P1 < 0.001 
3.00± 0.07 
P2 < 0.01 
The number of 
peeps in minks, n 13.52 ± 0.84 
6.11± 0.02 
P1 < 0.01 
3.17± 0.14 
P2 < 0.01 
Grooming, n 5.44 ± 0.60 3.06±0.01 P1 < 0.01 
2.10± 0.05 
P2 < 0.01 
Grooming, s 33.00 ± 3.20 27.21±0.07 P1 < 0.05 
43.81± 0.24 
P2< 0.01 
Number of 
defecation acts 
(boluses), n 
2.52 ± 0.28 0.38±0.004 P1 < 0.01 
1.15± 0.05 
P2< 0.01 
Number of 
urination acts, n 5.52 ± 0.70 
5.04±0.11 
P1 > 0.5 
3.72± 0.05 
P2 < 0.01 
Note. 1. (М1 ± m1), (M2 ± m2)and (M3 ± m3)are arithmetic 
averages with errors of indices; 
           2. P1 - calculated between ratios (М1 ± m1) and (M2 ± 
m2) groups of rats; 
           3. P2 - calculated between ratios (М1 ± m1) and (M3 ± 
m3) groups of rats. 
 As a result of modeling the state of 
magnesium deficiency, significant changes are 
observed in the central nervous system and 
vegetative nervous system of animals. Significantly, 
2.4 times (p <0.001), a decrease in the number of 
animal exits to the center and a significant increase 
in the number of stops by 1.5 times and their 
duration by 2.2 times (p <0.01 and p <0.01) , which 
together indicates a significant decrease in motor 
activity of animals. Relatively lower in comparison 
with the control data, the indicators characterizing 
the orientational-research behavior of rats, namely, 
the number of crossed squares, uprights and peeping 
in minks are reduced on average 2.2 times (p 
<0.001, p <0.001 and p <0, 01 respectively). At the 
same time, against the background of the 
development of a magnesium deficiency state, the 
emotional activity of animals is significantly 
reduced. The number and duration of grooming acts 
decreased by 1.8 times (p <0.05 and p <0.01), 
which, combined with a known decrease of 6.6 
times in bowel movements (boluses), indicates a 
worsening of emotional animal conditions. The 
animals looked frightened and inhibited, practically 
did not move around the area of the experimental 
setup. That is, when the animals one by one found 
themselves in an unfamiliar environment (placing 
the device in an “open field”), they showed 
extremely depressed behavior. On the contrary, 
when analyzing visual observations of animals with 
MDS, when they were next to other animals in the 
cage, the rats were nervous, fussed, jumped into the 
corner of the cage with little noise or movements, 
that is, they were in an overexcited state. It should 
be noted that the above changes in the emotional 
activity of animals indicate an imbalance in the 
processes of excitation/inhibition (or an imbalance 
between the processes of excitation and inhibition) 
in the central nervous system. 
 Thus, the development of the magnesium 
deficiency state is characterized by inhibition of 
motor activity and orientational research behavior 
and inhibition of the emotional activity of animals. 
 The use of magnesium oil solution in rats 
leads to the restoration of two of the three indicators 
characterizing the motor activity of animals (Table 
1). The number of exits to the center of the 
instrument and the number of stops of animals does 
not differ from the control data. But the duration of 
stops, which has been increased in animals with 
MMD, is increasing even more, by almost 100%.  
The animal ORB, characterized by the number of 
crossed squares, uprights, and staring, were reduced 
in animals with MMD relative to control, on 
average, twice, under the influence of the internal 
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course with "magnesium oil" decreases even more 
(by an average of 50%). At the same time, the 
emotional activity of the creatures has significantly 
improved, however, their duration exceeded not only 
the decreased level in rats with MMD but also 
exceeded the control values 1.3 times (p <0.01). The 
established fact indicates that most of the 
experiment the animals almost did not move around 
the device, were engaged in grooming (washing), 
did not fuss, and looked calm. The number of bowel 
movements recovered (increased) almost to the level 
of control (p <0.01), and the number of urinations, 
on the contrary, decreased one and a half times (p 
<0.05), that is, the emotional stress of the animals 
decreased. 
Consequently, the internal use of "magnesium oil" 
against the background of the development of a 
magnesium deficiency state has a powerful calming 
effect on the animals' ORB, slightly increases motor 
activity and leads to the restoration of vegetative 
reactions and a marked improvement in emotional 
activity. 
In the study of the functional state of the kidneys, 
the following data were obtained. In rats with 
MMD, the volume of daily diuresis was 
significantly increased (p <0.001) compared with the 
control data, but this is due to a noticeable activation 
of the process of water reabsorption in the renal 
tubules (p <0.001), while the tubular filtration rate 
decreases (p <0.001) (Table 2). Excretion of 
creatinine is also reduced (p <0.001), which 
indicates a decrease in renal excretory function. 
Significantly, the concentration and 9-fold decrease 
in excretion with daily urine of potassium ions 
decreases by a factor of 11 (p <0.01 and p <0.001), 
while the concentration of magnesium ions is 1.2 
times, and excretion with daily urine of magnesium 
ions is 2.4 times higher relative to the control data (p 
<0.05 and p <0.001, respectively), while the 
concentration and excretion with daily urine of 
sodium ions and chloride ions does not change.  
 The following changes are observed under 
the influence of “magnesium oil” in experimental 
animals: If the volume of daily diuresis in animals 
with MMD is increased by 1.3 times (p <0.001) due 
to a significant decrease in tubular reabsorption, then 
under the influence of the internal course of the 
solution “magnesium oil »It increases by 2.4 times 
(p <0.001) due to a significant decrease in tubular 
reabsorption. 
Table 2. Functional state of the rat kidney, (M ± m) 
                Indicators 
Group 1 Group 2 Group 3 
(М1 ± m1) (M2 ± m2) (M3 ± m3) 
Daily diuresis, ml / 
dm2 of body surface 
1.18 ± 0.13 
 
1.57 ± 0.005 
P1< 0.001 
2.78 ± 0.003 
P2 < 0.001 
The glomerular 
filtration rate, ml / 
(dm2 ∙ min) 
0.11 ± 
0.008 
 
0.09±0.0001  
P1 < 0.001 
0.09± 0.02 
P2< 0.001 
Tubular reabsorption, 
percentage to filter, % 
99.26 ± 
0.06 
 
98.78 
±0.002 
P1< 0.001 
97.78± 0.01 
P2 < 0.001 
Withdrawal of 
creatinine, mmol 
0.011 ± 
0.0008 
 
0.09 ± 0.001 
P1< 0.001 
0.09 ± 
0.0001 
P2 < 0001 
Urea excretion, mmol 0.64 ± 0.07 
 
0.69 ± 0.001 
P1> 0.2 
1.31 ± 0.02 
P2< 0.001 
Elimination of 
chlorides, mmol 
0.48 ± 0.03 
 
0.63 ± 0.004 
P1< 0.001 
0.53 ± 0.002 
P2 < 0.001 
pH of daily urine, u 7.67 ± 0.38 
 
7.04 ± 0.002 
P1 > 0.5 
6.18 ± 0.007 
P2 < 0.001 
Concentration of 
potassium ions in daily 
urine, mmol / l 
176.88 ± 
11.35 
 
16.17 ± 0.05 
P1< 0.01 
21.35 ± 0.13  
P2 < 0.01 
Daily excretion of 
potassium ions, mmol 0.19 ± 0.02  
0.021± 
0.001 
P1 < 0.001 
0.060 ± 
0.001 
P2 < 0.001 
Concentration of 
sodium ions in daily 
urine, mmol / l 
73.81 ± 
4.28 
 
67.75 ± 0.30 
P1 > 0.5 
113.72 ± 
0.69  
P2 < 0.001 
Daily excretion of 
sodium ions, mmol 
0.09 ± 0.02 
 
0.10 ± 0.001 
P1 > 0.5 
0.31 ± 0.002  
P2 < 0.001 
Concentration of 
chloride ions in daily 
urine, mmol / l 
321.03 ± 
20.42 
 
315.06 ± 
1.94 
P1 > 0.5 
95.64 ±0.97 
P2 < 0.001 
Daily excretion of 
chloride ions, mmol 
0.28 ± 0.06 
 
0.30 ± 0.003 
P1 > 0.2 
0.27 ± 0.004 
P2 > 0.5 
Concentration of 
magnesium ions in 
daily urine, mmol / l 
3.39 ± 0.02 4.15 ± 0.004  P1 < 0.05 
3.48 ± 0.01 
P2> 0.5 
Daily excretion of 
magnesium ions, 
mmol 
0.0033± 
0.0003 
 
0.0080±0.00
02 
     P1 < 
0.0001 
0.0100±0.00
01 
P2< 0.001 
Note. 1. (М1 ± m1), (M2 ± m2)and (M3 ± m3)are arithmetic 
averages with errors of indices; 
           2. P1 - calculated between ratios (М1 ± m1) and (M2 ± 
m2) groups of rats; 
           3. P2 - calculated between ratios (М1 ± m1) and (M3 ± 
m3) groups of rats. 
 The glomerular filtration rate and creatinine 
excretion remained at the same reduced level as rats 
with MMD (p <0.001 and p <0.001), but urea 
excretion increased 2-fold (p <0.001). The pH 
response of the urine shifts slightly to the acidic 
direction (p <0.001). Significantly reduced 
concentration and excretion of potassium ions 
recovered somewhat under the influence of the 
conducted course (p <0.001 and p <0.001). An 
increase of 1.5 times the urine concentration of 
sodium ions and an increase of 3.4 times their 
excretion with daily urine (p <0.001 and p <0.001) 
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were observed, although the concentration in the 
urine of chloride ions decreased 3.8 times (p 
<0.001). The concentration of magnesium ions in 
the urine recovered to the level of control, but their 
excretion, which was increased by 2.4 times in the 
background of MMD, under the influence of 
"Magnesium oil" increased by 3 times (p <0.01 and 
p <0.01, respectively) ). 
 The data in Table 3 show the changes in the 
electrolyte composition of the blood of rats with 
MMD and rats, which in the background of the 
development of MMD received a solution of 
"Magnesium oil". 
 
Table 3. Indicators of electrolyte blood composition, (M ± m) 
                
Indicators 
Group 1 Group 2 Group 3 
(М1 ± m1) (M2 ± m2) (M3 ± m3) 
Concentration of 
magnesium ions 
in blood, mmol / l 
0.90 ± 0.03 
 
0.59 ± 0.05 
P1 < 0.001 
0.80 ± 0.06 
P2 > 0.2 
Concentration of 
potassium ions in 
the blood, mmol / 
l 
3.75 ± 0.31 
 
3.05 ± 0.001  
P1< 0.05 
3.46 ± 0.24 
P2> 0.2 
Concentration of 
sodium ions in 
the blood, mmol / 
l 
132.00 ± 
0.13 
 
138.08 ±0.02  
P1< 0.001 
132.83± 0.81 
P2 > 0.5 
Concentration of 
calcium ions in 
the blood, mmol / 
l 
1.81 ± 0.02 1.40 ± 0.03 P1 < 0.001 
1.52 ± 0.001 
P2 < 0.001 
Concentration of 
ionized calcium 
in the blood, 
mmol / l 
2.62 ± 0.01 
 
2.15 ± 0.02 
P1< 0.001 
1.96 ± 0.02 
P2< 0.001 
Concentration of 
chloride ions in 
blood, mmol / l 
146.77 ± 
1.41 
 
0.130 ± 0.004 
P1< 0.001 
124.70 ± 1.54 
P2 < 0.001 
Note. 1. (М1 ± m1), (M2 ± m2) and (M3 ± m3)are arithmetic 
averages with errors of indices; 
2. P1 - calculated between ratios (М1 ± m1) and (M2 ± m2) 
groups of rats; 
           3. P2 - calculated between ratios (М1 ± m1) and (M3 ± 
m3) groups of rats. 
 The electrolyte composition of the blood of 
rats with magnesium deficiency is characterized by a 
decrease in the concentration of magnesium ions by 
35%, potassium ions by 19%, and chlorine ions by 
12%. At the same time, the concentration of sodium 
ions increased by 5%. The concentration of calcium 
ions and ionized calcium significantly decreased by 
23% and 18% respectively. The internal use of the 
magnesium oil solution led to a complete restoration 
of the concentration of magnesium, potassium and 
sodium ions. However, the concentration of chlorine 
ions, calcium ions, and ionized calcium significantly 
decreased, both in comparison with the group of rats 
with pathology and in comparison with the control 
group - by 15%, 16%, and 25%. 
 So, the established effects from the use of the 
solution of "magnesium oil" indicate a restoring 
effect on changes in the electrolyte composition of 
the blood and the functional state of the kidneys of 
rats with MMD. An increase in urea excretion by 
104% indicates an increase in detoxification 
function and an increase in excretion of sodium ions 
by 244% is associated with a significant decrease in 
tubular reabsorption, which in turn leads to an 
increase in daily urine output by 135%. Against this 
background, an even greater increase in the 
excretion of magnesium ions in comparison with the 
MMD model and the level of control (against the 
background of the restoration of its content in the 
blood serum) indicates a significant decrease in 
magnesium deficiency in the body, which is 
confirmed, although by a slight, but significant 
increase in the excretion of potassium ions and 
indicates the restoration of electrolyte balance in the 
body of rats. 
Conclusions 
An experimental model of magnesium deficiency in 
rats caused by a prolonged hypo-magnesium diet is 
characterized by significant changes in the 
functional state of the nervous system and kidneys. 
The use of balneological means "Magnesium oil" 
can significantly reduce the negative manifestations 
of magnesium deficiency. This makes it possible to 
test this technique in clinical practice. 
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